Zobrazeno 1 - 10
of 1 300
pro vyhledávání: '"Rajender Reddy"'
Publikováno v:
In The Lancet Gastroenterology & Hepatology August 2024 9(8):745-757
Autor:
Bangaru, Mallikarjuna, Nukala, Satheesh Kumar, Azam, Mohammad, Al-Resayes, Saud I., Karnekanti, Rajender Reddy, Manchal, Ravinder, Thirukovela, Narasimha Swamy
Publikováno v:
In Journal of Molecular Structure 15 October 2024 1314
Autor:
Ethan Weinberg, Suditi Rahematpura, Stevan A. Gonzalez, Manhal J. Izzy, Douglas A. Simonetto, R. Todd Frederick, Raymond A. Rubin, Jade Ikahihifo-Bender, Maggie Harte, Grace Kim-Lee, Sherry Witkiewicz, William Tobin, Khurram Jamil, Zachary Fricker, K. Rajender Reddy
Publikováno v:
Contemporary Clinical Trials Communications, Vol 36, Iss , Pp 101211- (2023)
Background: Hepatorenal syndrome-acute kidney injury (HRS-AKI) carries significant morbidity and mortality among those with end-stage liver disease. Bolus terlipressin for treatment of HRS-AKI received FDA approval in September 2022. US implementatio
Externí odkaz:
https://doaj.org/article/69b11afd91bc4de8bc30e73f33e63219
Autor:
Surukonti, Srikanth Reddy, Manabolu Surya, Surendra Babu, Katari, Naresh Kumar, Yerla, Rajender Reddy
Publikováno v:
In Journal of Pharmaceutical and Biomedical Analysis 25 October 2023 235
Autor:
Banda, Rajender Reddy, Halge, Devidas I., Narwade, Vijaykiran N., Kaawash, Nabeel M.S., Thabit, Mohammed Y.H., Alegaonkar, Prashant S., Bogle, Kashinath A.
Publikováno v:
In Physica B: Condensed Matter 1 August 2023 662
Autor:
Peter P. Reese, MD, PhD, Joshua M. Diamond, MD, MSCE, David S. Goldberg, MD, MSCE, Vishnu Potluri, MD, MPH, Stacey Prenner, MD, Emily A. Blumberg, MD, Vivianna M. Van Deerlin, MD, PhD, K. Rajender Reddy, MD, Heather Mentch, MBE, Richard Hasz, MFS, CPTC, Ashley Woodards, MPH, Caren Gentile, MS, Jennifer Smith, BS, Christian Bermudez, MD, Maria M. Crespo, MD
Publikováno v:
Transplantation Direct, Vol 9, Iss 7, p e1504 (2023)
Background. SHELTER is a trial of transplanting lungs from deceased donors with hepatitis C virus (HCV) infection into HCV-negative candidates (sponsor: Merck; NCT03724149). Few trials have reported outcomes using thoracic organs from HCV-RNA+ donors
Externí odkaz:
https://doaj.org/article/fc42ce99f44c427a9839198da701431d
Autor:
Anand V. Kulkarni, Raghuram Reddy, Juan Pablo Arab, Mithun Sharma, Sameer Shaik, Sowmya Iyengar, Naveen Kumar, Sabreena, Rajesh Gupta, Giri Vishwanathan Premkumar, Balachandran Palat Menon, Duvvur Nageshwar Reddy, Padaki Nagaraja Rao, K. Rajender Reddy
Publikováno v:
Annals of Hepatology, Vol 28, Iss 4, Pp 101098- (2023)
Introduction and Objectives: Lately, there has been a steady increase in early liver transplantation for alcohol-associated hepatitis (AAH). Although several studies have reported favorable outcomes with cadaveric early liver transplantation, the exp
Externí odkaz:
https://doaj.org/article/27216afc72ee4c39bbe12e9c693da643
Autor:
Calvin Q. Pan, Nezam H. Afdhal, Victor Ankoma‐Sey, Ho Bae, Michael P. Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie‐Won Hann, W. Ray Kim, Paul Kwo, Scott Milligan, Myron J. Tong, K. Rajender Reddy
Publikováno v:
Hepatology Communications, Vol 6, Iss 8, Pp 1881-1894 (2022)
Abstract Real‐world data are limited on tenofovir alafenamide (TAF). We aimed to study TAF real‐world outcomes with other first‐line regimens for chronic hepatitis B (CHB). We enrolled patients with CHB from 10 centers retrospectively and follo
Externí odkaz:
https://doaj.org/article/c069a6f091ce4455a5cb4d4d17687cc2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Steven Flamm, Eric Lawitz, Brian Borg, Michael Charlton, Charles Landis, K. Rajender Reddy, Mitchell Shiffman, Angel Alsina, Charissa Chang, Natarajan Ravendhran, Candido Hernandez, Christophe Hézode, Stacey Scherbakovsky, Renee-Claude Mercier, Didier Samuel
Publikováno v:
Viruses, Vol 15, Iss 10, p 2026 (2023)
A fixed-dose combination of sofosbuvir/velpatasvir (SOF/VEL) plus weight-based ribavirin (RBV) for 12 weeks is recommended for the treatment of patients with hepatitis C virus (HCV)-associated decompensated cirrhosis. However, large global studies, w
Externí odkaz:
https://doaj.org/article/620ad64d8bc644198848a98512cd84c1